Cargando…
miR-101-3p Contributes to α-Synuclein Aggregation in Neural Cells through the miR-101-3p/SKP1/PLK2 Pathway
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive neuronal loss in different brain regions, including the dopaminergic (DA) neurons of the substantia nigra pars compacta (SNc). The aggregation of α-synuclein (α-Syn) plays an essential role in the progression...
Autores principales: | Zhang, Min, Liu, Wei, Zhang, Qingan, Hu, Hongfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216813/ https://www.ncbi.nlm.nih.gov/pubmed/34234930 http://dx.doi.org/10.1155/2021/6147434 |
Ejemplares similares
-
Investigating VEGF. miR-145-3p, and miR-101-3p Expression in Patients with Cholangiocarcinoma
por: Calastri, Maria Clara Jessica, et al.
Publicado: (2022) -
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018) -
miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy
por: Xylaki, Mary, et al.
Publicado: (2023) -
Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer
por: Zeng, Weiwei, et al.
Publicado: (2020) -
miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome
por: Carini, Giulia, et al.
Publicado: (2022)